Pra Health (PRAH) Forecast, Price Target & Analyst Ratings

NASDAQ:PRAH

Current stock price

165.21
-2.8 (-1.67%)
At close:
166.01
+0.8 (+0.48%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Pra Health (PRAH).

Forecast Snapshot

Consensus Price Target

Price Target
$171.11
+ 3.57% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 1, 2022
Period
Q2 / 2021
EPS Estimate
$1.47
Revenue Estimate
932.28M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
60.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$171.11
Upside
+ 3.57%
From current price of $165.21 to mean target of $171.11, Based on 4 analyst forecasts
Low
$161.60
Median
$172.38
High
$183.75

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

4 Wall Street analysts provided a forecast for the next 12 months for PRAH. The average price target is 171.11 null. This implies a price increase of 3.57% is expected in the next year compared to the current price of 165.21.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PRAH Current Analyst RatingPRAH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PRAH Historical Analyst RatingsPRAH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
60.00%
PRAH was analyzed by 4 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about PRAH.
In the previous month the buy percentage consensus was at a similar level.
Only 4 analysts analyzed PRAH. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 1, 2022
Period
Q2 / 2021
EPS Estimate
$1.47
Revenue Estimate
932.28M
Revenue Q2Q
N/A
EPS Q2Q
71.43%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

PRAH is expected to report earnings on 3/1/2022. The consensus EPS estimate for the next earnings is 1.47 null and the consensus revenue estimate is 932.28M null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
PRAH revenue by date.PRAH revenue by date.
N/AN/A
14.95%		N/A
22.39%		N/A
48.26%		N/A
7.40%		N/A
2.48%		N/A
19.32%		N/A
6.85%		N/A
8.18%		N/A
5.92%		N/A
7.51%
EBITDA
YoY % growth
PRAH ebitda by date.PRAH ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PRAH ebit by date.PRAH ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
PRAH operating margin by date.PRAH operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
PRAH eps by date.PRAH eps by date.
1.992.53
27.14%		3.33
31.62%		4.29
28.83%		5.18
20.75%		4.76
-8.11%		N/A
29.21%		N/A
12.99%		N/A
8.63%		N/A
8.64%		N/A

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 21 Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		1.47
71.43%		1.58
21.31%		1.74
12.33%		1.57
15.99%		1.71
15.75%		1.76
11.51%		1.90
9.31%		1.57
-0.01%		1.75
2.81%		1.84
4.41%		1.96
2.89%
Revenue
Q2Q % growth		932.28M943.903M976.401M992.945M
13.74%		1.003B
7.57%		1.02B
8.08%		1.058B
8.31%		1.06B
6.80%		1.083B
7.97%		1.104B
8.23%		1.137B
7.53%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PRAH Yearly Revenue VS EstimatesPRAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRAH Yearly EPS VS EstimatesPRAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.62%
EPS Next 5 Year
11.49%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.31%
Revenue Next 5 Year
9.45%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Pra Health / PRAH Forecast FAQ

What do analysts expect the price target to be for Pra Health (PRAH)?

4 analysts have analysed PRAH and the average price target is 171.11 null. This implies a price increase of 3.57% is expected in the next year compared to the current price of 165.21.

What is the next earnings date for PRAH stock?

Pra Health (PRAH) will report earnings on 2022-03-01, after the market close.

Can you provide the consensus estimates for Pra Health next earnings?

The consensus EPS estimate for the next earnings of Pra Health (PRAH) is 1.47 null and the consensus revenue estimate is 932.28M null.

What is the number of analysts for PRAH stock?

The number of analysts covering Pra Health (PRAH) is 4.